99mTc-3PRGD2 |
99mTc-3PRGD2 |
Phase 3 Clinical |
Peking University |
Lymphatic Metastasis; Lung Neoplasms |
Details
|
Alfatide[18F] |
18F-AlF-NOTA-PRGD2; 18F-alfatide; alfatide II; AlF-NOTA-PRGD2-[18F] |
Phase 3 Clinical |
Jiangsu Smk Pharmaceutical Co Ltd, Taizhou Kairui Pharmaceutical Technology Co Ltd |
Carcinoma, Bronchogenic; Head and Neck Neoplasms; Neoplasms; Soft Tissue Neoplasms; Breast Neoplasms; Contrast agents; Lymphoma |
Details
|
IDL-2965 |
IDL-2965 |
Phase 2 Clinical |
Indalo Therapeutics Inc |
Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis |
Details
|
AS-101 |
PRX-0001/AS101; WAX-120337; IVAX-Q-101; IVX-Q-101; CB-06-02; AS-101; PRX-001; PRX-0002/AS101 |
Phase 2 Clinical |
Biomas Ltd |
Alopecia; HIV Infections; Warts; Myelodysplastic Syndromes; Psoriasis; Leukemia, Myeloid, Acute; Thrombocytopenia; Macular Degeneration; Dermatitis, Atopic; Condylomata Acuminata |
Details
|
Nesvategrast |
OTT-166(OcuTerra Therapeutics); SF-0166 |
Phase 2 Clinical |
Scifluor Life Sciences Inc, OcuTerra Therapeutics Inc |
Diabetic macular oedema; Diabetic Retinopathy; Macular Degeneration |
Details
|
Ga-68 NODAGA-RGD |
[68Ga]Theranost; Theranost 68Ga-RGD |
Phase 1 Clinical |
Advanced Imaging Projects, Zentralklinik Bad Berka, National Cancer Institute |
Neovascularization, Pathologic; Lung Neoplasms |
Details
|
Risuteganib |
ALG-1001; AM011; AM-011(Allegro Ophthalmics) |
Phase 1 Clinical |
Allegro Ophthalmics Llc |
Diabetic macular oedema; Geographic Atrophy; Macular Degeneration; Diabetic Retinopathy |
Details
|
68Ga-NOTA-BBN-RGD |
68Ga-NOTA-BBN-RGD |
Phase 1 Clinical |
Peking Union Medical College Hospital |
Breast Neoplasms; Prostatic Neoplasms |
Details
|
BGC-0222 |
BGC0222; BGC-0222 |
Phase 1 Clinical |
Gaorui Yaoye (Beijing) Technologies Co Ltd, Brightgene Bio-Medical Technology Co Ltd |
Solid tumours |
Details
|
Antiangiotide |
HM-3; IIM-3 |
Phase 1 Clinical |
Inner Mongolia Tianqi Pharmaceutical Group Co Ltd, China Pharmaceutical University |
Solid tumours; Liver Neoplasms; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
68Ga-NOTA-3PTATE-RGD |
68Ga-NOTA-3PTATE-RGD; 68Ga-NOTA-3P-TATE-RGD |
Phase 1 Clinical |
Peking Union Medical College Hospital |
Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lung Neoplasms |
Details
|
Transferrin |
OCU-200 |
Phase 1 Clinical |
Ocugen Inc |
Wet Macular Degeneration; Diabetic macular oedema; Diabetic Retinopathy |
Details
|
VIP-236 |
VIP-236 |
Phase 1 Clinical |
Bayer AG |
Solid tumours; Neoplasms |
Details
|
177Lu-FF-58 |
177Lu-FF58; 177-Lu-FF-58; 177Lu-FF-58; [177Lu]Lu-FF58 |
Phase 1 Clinical |
Advanced Accelerator Applications Sa |
Esophageal Neoplasms; Stomach Neoplasms; Glioblastoma; Carcinoma, Pancreatic Ductal |
Details
|
68Ga-FAPI-RGD |
68Ga-FAPI-RGD |
Phase 1 Clinical |
Peking Union Medical College Hospital |
Lung Neoplasms |
Details
|
68Ga-HX01 |
68GaHX01; 68Ga-HX01 |
Phase 1 Clinical |
Hexin (Suzhou) Pharmaceutical Technology Co Ltd |
Solid tumours; Contrast agents |
Details
|
(68)Ga-RGD |
|
Phase 1 Clinical |
Peking Union Medical College Hospital |
Keloid |
Details
|
fb-PMT |
NP-100; NP-751 |
Phase 1 Clinical |
NanoPharmaceuticals LLC |
Glioma |
Details
|
ProAgio |
|
Phase 1 Clinical |
National Cancer Institute |
Solid tumours; Pancreatic Neoplasms |
Details
|
[68Ga]-FF58 |
|
Phase 1 Clinical |
Novartis Pharma Ag |
Stomach Neoplasms; Esophageal Neoplasms; Glioblastoma; Brain Neoplasms; Carcinoma, Pancreatic Ductal |
Details
|
ACT-50 |
ACT-50 |
Phase 1 Clinical |
Xiamen Amoytop Biotech Co Ltd |
Neoplasms; Carcinoma, Pancreatic Ductal |
Details
|
Pagantangentide |
|
Phase 1 Clinical |
Nanjing Anji Biological Technology Co Ltd, Jiangsu Aotexin Biomedical Technology Co Ltd, China Pharmaceutical University |
Arthritis, Rheumatoid; Rheumatic Diseases |
Details
|
99mTc-3PRGD2 |
99mTc-3PRGD2 |
Phase 3 Clinical |
Peking University |
Lymphatic Metastasis; Lung Neoplasms |
Details
|
Alfatide[18F] |
18F-AlF-NOTA-PRGD2; 18F-alfatide; alfatide II; AlF-NOTA-PRGD2-[18F] |
Phase 3 Clinical |
Jiangsu Smk Pharmaceutical Co Ltd, Taizhou Kairui Pharmaceutical Technology Co Ltd |
Carcinoma, Bronchogenic; Head and Neck Neoplasms; Neoplasms; Soft Tissue Neoplasms; Breast Neoplasms; Contrast agents; Lymphoma |
Details
|
IDL-2965 |
IDL-2965 |
Phase 2 Clinical |
Indalo Therapeutics Inc |
Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis |
Details
|
AS-101 |
PRX-0001/AS101; WAX-120337; IVAX-Q-101; IVX-Q-101; CB-06-02; AS-101; PRX-001; PRX-0002/AS101 |
Phase 2 Clinical |
Biomas Ltd |
Alopecia; HIV Infections; Warts; Myelodysplastic Syndromes; Psoriasis; Leukemia, Myeloid, Acute; Thrombocytopenia; Macular Degeneration; Dermatitis, Atopic; Condylomata Acuminata |
Details
|
Nesvategrast |
OTT-166(OcuTerra Therapeutics); SF-0166 |
Phase 2 Clinical |
Scifluor Life Sciences Inc, OcuTerra Therapeutics Inc |
Diabetic macular oedema; Diabetic Retinopathy; Macular Degeneration |
Details
|
Ga-68 NODAGA-RGD |
[68Ga]Theranost; Theranost 68Ga-RGD |
Phase 1 Clinical |
Advanced Imaging Projects, Zentralklinik Bad Berka, National Cancer Institute |
Neovascularization, Pathologic; Lung Neoplasms |
Details
|
Risuteganib |
ALG-1001; AM011; AM-011(Allegro Ophthalmics) |
Phase 1 Clinical |
Allegro Ophthalmics Llc |
Diabetic macular oedema; Geographic Atrophy; Macular Degeneration; Diabetic Retinopathy |
Details
|
68Ga-NOTA-BBN-RGD |
68Ga-NOTA-BBN-RGD |
Phase 1 Clinical |
Peking Union Medical College Hospital |
Breast Neoplasms; Prostatic Neoplasms |
Details
|
BGC-0222 |
BGC0222; BGC-0222 |
Phase 1 Clinical |
Gaorui Yaoye (Beijing) Technologies Co Ltd, Brightgene Bio-Medical Technology Co Ltd |
Solid tumours |
Details
|
Antiangiotide |
HM-3; IIM-3 |
Phase 1 Clinical |
Inner Mongolia Tianqi Pharmaceutical Group Co Ltd, China Pharmaceutical University |
Solid tumours; Liver Neoplasms; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
68Ga-NOTA-3PTATE-RGD |
68Ga-NOTA-3PTATE-RGD; 68Ga-NOTA-3P-TATE-RGD |
Phase 1 Clinical |
Peking Union Medical College Hospital |
Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lung Neoplasms |
Details
|
Transferrin |
OCU-200 |
Phase 1 Clinical |
Ocugen Inc |
Wet Macular Degeneration; Diabetic macular oedema; Diabetic Retinopathy |
Details
|
VIP-236 |
VIP-236 |
Phase 1 Clinical |
Bayer AG |
Solid tumours; Neoplasms |
Details
|
177Lu-FF-58 |
177Lu-FF58; 177-Lu-FF-58; 177Lu-FF-58; [177Lu]Lu-FF58 |
Phase 1 Clinical |
Advanced Accelerator Applications Sa |
Esophageal Neoplasms; Stomach Neoplasms; Glioblastoma; Carcinoma, Pancreatic Ductal |
Details
|
68Ga-FAPI-RGD |
68Ga-FAPI-RGD |
Phase 1 Clinical |
Peking Union Medical College Hospital |
Lung Neoplasms |
Details
|
68Ga-HX01 |
68GaHX01; 68Ga-HX01 |
Phase 1 Clinical |
Hexin (Suzhou) Pharmaceutical Technology Co Ltd |
Solid tumours; Contrast agents |
Details
|
(68)Ga-RGD |
|
Phase 1 Clinical |
Peking Union Medical College Hospital |
Keloid |
Details
|
fb-PMT |
NP-100; NP-751 |
Phase 1 Clinical |
NanoPharmaceuticals LLC |
Glioma |
Details
|
ProAgio |
|
Phase 1 Clinical |
National Cancer Institute |
Solid tumours; Pancreatic Neoplasms |
Details
|
[68Ga]-FF58 |
|
Phase 1 Clinical |
Novartis Pharma Ag |
Stomach Neoplasms; Esophageal Neoplasms; Glioblastoma; Brain Neoplasms; Carcinoma, Pancreatic Ductal |
Details
|
ACT-50 |
ACT-50 |
Phase 1 Clinical |
Xiamen Amoytop Biotech Co Ltd |
Neoplasms; Carcinoma, Pancreatic Ductal |
Details
|
Pagantangentide |
|
Phase 1 Clinical |
Nanjing Anji Biological Technology Co Ltd, Jiangsu Aotexin Biomedical Technology Co Ltd, China Pharmaceutical University |
Arthritis, Rheumatoid; Rheumatic Diseases |
Details
|